AAAAAA
Results: 51-75/90
Authors:
LI FZ
HORAIST CK
HU ZY
RUEF J
YAN CN
FRITZ PH
WANG DH
RUNGE MS
Citation: Fz. Li et al., DIFFERENTIAL EXPRESSION OF RAB-13, A LOW-MOLECULAR-WEIGHT G-PROTEIN INVOLVED IN VESICULAR SECRETION, IN BALLOON-INJURED BABOON ARTERIES, Circulation, 94(8), 1996, pp. 3731-3731
Authors:
RUNGE MS
YAKES FM
YAN CN
FREEMAN B
VANHOUTEN B
Citation: Ms. Runge et al., ANALYSIS OF DNA-DAMAGE IN HUMAN-CELLS EXPOSED TO REACTIVE OXYGEN SPECIES, Circulation, 94(8), 1996, pp. 4147-4147
Authors:
RUNGE MS
HARKER LA
BODE C
RUEF J
KELLY AB
MARZEC UM
ALLEN E
CABAN R
SHAW SY
HABER E
HANSON SR
Citation: Ms. Runge et al., ENHANCED THROMBOLYTIC AND ANTITHROMBOTIC POTENCY OF A FIBRIN-TARGETEDPLASMINOGEN-ACTIVATOR IN BABOONS, Circulation, 94(6), 1996, pp. 1412-1422
Authors:
BONE BG
DESHPANDE US
RUNGE MS
TAI A
TENG W
SCARBOROUGH RM
CONLEY PB
BABA D
REYNOLDS EE
RAMAKRISHNAN V
Citation: Bg. Bone et al., EVIDENCE FOR A NOVEL THROMBIN RECEPTOR ON RAT PLATELETS, Blood, 88(10), 1996, pp. 2482-2482
Authors:
SCHMEDTJE JF
LIU WL
JI YS
THOMPSON TM
RUNGE MS
Citation: Jf. Schmedtje et al., EVIDENCE OF HYPOXIA-INDUCIBLE FACTOR-I IN VASCULAR ENDOTHELIAL AND SMOOTH-MUSCLE CELLS, Biochemical and biophysical research communications, 220(3), 1996, pp. 687-691
Authors:
BODE C
NORDT TK
PETER K
SMALLING RW
RUNGE MS
KUBLER W
Citation: C. Bode et al., PATENCY TRIALS WITH RETEPLASE (R-PA) - WHAT DO THEY TELL US, The American journal of cardiology, 78, 1996, pp. 16-19
Authors:
CUTLER D
BODE C
RUNGE MS
Citation: D. Cutler et al., THE PROMISE OF NEW GENETICALLY-ENGINEERED PLASMINOGEN ACTIVATORS, Journal of vascular and interventional radiology, 6(6), 1995, pp. 3-7
Authors:
RUNGE MS
SCHMEDTJE JF
HORAIST C
LI F
WILCOX JN
BODE C
Citation: Ms. Runge et al., NEW APPROACHES TO INHIBITING THROMBINS EFFECT ON THE BLOOD-VESSEL WALL, Fibrinolysis, 9, 1995, pp. 69-73
Authors:
BODE C
KOHLER B
SMALLING RW
RUNGE MS
Citation: C. Bode et al., RETEPLASE (R-PA) - A NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR, Fibrinolysis, 9, 1995, pp. 97-99
Authors:
RAO GN
RUNGE MS
ALEXANDER RW
Citation: Gn. Rao et al., HYDROGEN-PEROXIDE ACTIVATION OF CYTOSOLIC PHOSPHOLIPASE A(2) IN VASCULAR SMOOTH-MUSCLE CELLS, Biochimica et biophysica acta. Molecular cell research, 1265(1), 1995, pp. 67-72
Authors:
RAO GN
ALEXANDER RW
RUNGE MS
Citation: Gn. Rao et al., LINOLEIC-ACID AND ITS METABOLITES, HYDROPEROXYOCTADECADIENOIC ACIDS, STIMULATE C-FOS, C-JUN, AND C-MYC MESSENGER-RNA EXPRESSION, MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION, AND GROWTH IN RAT AORTIC SMOOTH-MUSCLE CELLS, The Journal of clinical investigation, 96(2), 1995, pp. 842-847
Authors:
RAO GN
DELAFONTAINE P
RUNGE MS
Citation: Gn. Rao et al., THROMBIN STIMULATES PHOSPHORYLATION OF INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR, INSULIN-RECEPTOR SUBSTRATE-1, AND PHOSPHOLIPASE C-GAMMA-1 IN RAT AORTIC SMOOTH-MUSCLE CELLS, The Journal of biological chemistry, 270(46), 1995, pp. 27871-27875
Authors:
CHAIKOF EL
CABAN R
YAN CN
RAO GN
RUNGE MS
Citation: El. Chaikof et al., GROWTH-RELATED RESPONSES IN ARTERIAL SMOOTH-MUSCLE CELLS ARE ARRESTEDBY THROMBIN RECEPTOR ANTISENSE SEQUENCES, The Journal of biological chemistry, 270(13), 1995, pp. 7431-7436
Authors:
CAPERS Q
RAJAGOPALAN S
FUKUI T
GRIENDLING KK
RUNGE MS
TAYLOR WR
Citation: Q. Capers et al., EFFECT OF ANGIOTENSIN-II INFUSION AND HYPERTENSION ON THROMBIN RECEPTOR MESSENGER-RNA CONTENT OF RAT AORTAE, Circulation, 92(8), 1995, pp. 1345-1345
Authors:
BODE C
MEHWALD P
SCHMEDTJE J
HARKER LA
HANSON SR
RUNGE MS
Citation: C. Bode et al., ENHANCED ANTITHROMBOTIC POTENCY OF FIBRIN-TARGETED RECOMBINANT HIRUDIN IN A NONHUMAN PRIMATE MODEL, Circulation, 92(8), 1995, pp. 3289-3289
Authors:
LI FZ
RAO GN
BAYKAL D
CARR BK
YAN CN
RUNGE MS
Citation: Fz. Li et al., CLONING AND STRUCTURAL-ANALYSIS OF THE HUMAN THROMBIN RECEPTOR GENE, Circulation, 92(8), 1995, pp. 3326-3326
Authors:
SCHMEDTJE JF
LIU WL
RUNGE MS
Citation: Jf. Schmedtje et al., EVIDENCE OF A HYPOXIA-INDUCIBLE FACTOR IN VASCULAR ENDOTHELIAL AND SMOOTH-MUSCLE CELLS, Circulation, 92(8), 1995, pp. 3601-3601
Authors:
CUTLER DA
RUNGE MS
Citation: Da. Cutler et Ms. Runge, 86 YEARS OF BUERGERS-DISEASE - WHAT HAVE WE LEARNED, The American journal of the medical sciences, 309(2), 1995, pp. 74-75
Authors:
HARKER LA
HANSON SR
RUNGE MS
Citation: La. Harker et al., THROMBIN HYPOTHESIS OF THROMBUS GENERATION AN VASCULAR LESION FORMATION, The American journal of cardiology, 75(6), 1995, pp. 12-17
Authors:
BAYKAL D
SCHMEDTJE JF
RUNGE MS
Citation: D. Baykal et al., ROLE OF THE THROMBIN RECEPTOR IN RESTENOSIS AND ATHEROSCLEROSIS, The American journal of cardiology, 75(6), 1995, pp. 82-87
Authors:
BODE C
NORDT TK
RUNGE MS
Citation: C. Bode et al., THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION - SELECTED RECENTDEVELOPMENTS, Annals of hematology, 69(4), 1994, pp. 190000035-190000040
Authors:
BODE C
RUNGE MS
HABER E
Citation: C. Bode et al., FIBRIN-TARGETED RECOMBINANT HIRUDIN, Journal of cellular biochemistry, 1994, pp. 181-181
Authors:
HAYZER DJ
SHOJI M
KIM TM
RUNGE MS
HANSON SR
Citation: Dj. Hayzer et al., ALTERNATIVE SPLICING OF THE MESSENGER-RNA ENCODING BABOON GLYCOPROTEIN RECEPTOR GPIIB, Gene, 151(1-2), 1994, pp. 267-271
Authors:
LOVE TW
QUERTERMOUS T
RUNGE MS
MICHELSON KD
MATSUEDA GR
HABER E
Citation: Tw. Love et al., ATTACHMENT OF AN ANTIFIBRIN ANTIBODY TO THE AMINO-TERMINUS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IMPAIRS STIMULATION BY FIBRIN, Fibrinolysis, 8(5), 1994, pp. 326-332
Authors:
KAI H
GRIENDLING KK
LASSEGUE B
OLLERENSHAW JD
RUNGE MS
ALEXANDER RW
Citation: H. Kai et al., AGONIST-INDUCED PHOSPHORYLATION OF THE VASCULAR TYPE-1 ANGIOTENSIN-IIRECEPTOR, Hypertension, 24(4), 1994, pp. 523-527